Following a request from the European Commission, the
EFSA
Panel on Nutrition, Novel Foods and Food Allergens (
NDA
) was asked to deliver an opinion on mung bean protein as a novel food (
NF
) pursuant to Regulation (
EU
) 2015/2283. The
NF
, which is the subject of the application, is mung bean protein extracted from seeds of the plant
Vigna radiata
. The
NF
is proposed to be used as a food ingredient added to ‘protein products, excluding products covered in category 1.8’. The target population is the general population. The maximum estimated intake of the
NF
is 758 and 260 mg/kg body weight (bw) per day in children and adults, respectively. The major constituents of this
NF
are protein (~85%), fat (3–4%) and moisture (3–5.5%). The
NF
is rich in protein which is well digestible and provides sufficient amounts of most essential amino acids but only limited amounts of sulfur‐containing amino acids. The Panel notes that the cumulative exposure to the minerals analysed does not raise concern. The reported values for the levels of antinutritional factors in the
NF
are comparable to those in other foodstuffs. The Panel considers that taking into account the composition of the
NF
and the proposed conditions of use, consumption of the
NF
is not nutritionally disadvantageous. No toxicological studies with the
NF
s were provided by the applicant; however, the Panel considers that no toxicological studies are required on this
NF
. This
NF
has the potential capacity to sensitise individuals and to induce allergic reactions in individuals allergic to soybean, peanuts, lupin and to birch pollen. The Panel considers that the
NF
, i.e. mung bean protein, is safe at the proposed conditions of use.